Wade, Kaitlin H.
Lam, Brian Y. H. http://orcid.org/0000-0002-3638-9025
Melvin, Audrey
Pan, Warren
Corbin, Laura J. http://orcid.org/0000-0002-4032-9500
Hughes, David A. http://orcid.org/0000-0002-9644-8998
Rainbow, Kara
Chen, Jian-Hua
Duckett, Katie
Liu, Xiaoming
Mokrosiński, Jacek http://orcid.org/0000-0001-5008-0457
Mörseburg, Alexander
Neaves, Sam
Williamson, Alice
Zhang, Chen
Farooqi, I. Sadaf
Yeo, Giles S. H. http://orcid.org/0000-0001-8823-3615
Timpson, Nicholas J. http://orcid.org/0000-0002-7141-9189
O’Rahilly, Stephen http://orcid.org/0000-0003-2199-4449
Funding for this research was provided by:
Wellcome Trust (202802/Z/16/Z, 202802/Z/16/Z, 095515/Z/11/Z, 208363/Z/17/Z, 204813/Z/16/Z, 202802/Z/16/Z, 098497/Z/12/Z, 202802/Z/16/Z)
RCUK | Medical Research Council (MC_UU_00014/1, MC_UU_00014/5, MC_UU_00014/1)
RCUK | Biotechnology and Biological Sciences Research Council (BB/S017593/1)
Article History
Received: 30 October 2020
Accepted: 12 April 2021
First Online: 27 May 2021
Competing interests
: S.O.R. has undertaken remunerated consultancy work for Pfizer, AstraZeneca, GSK and ERX Pharmaceuticals. The remaining authors declare no competing interests.